Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery

Journal of Hepatology

Volumn 57, Issue 5, 2012, Pages 1090-1096

  Anty, Rodolphe ^a,b,c   Marjoux, Sophie ^d   Iannelli, Antonio ^a,b,c   Patouraux, Stéphanie ^a,b,c   Schneck, Anne Sophie ^a,b,c   Bonnafous, Stéphanie ^a,b,c   Gire, Camille ^b   Amzolini, Anca ^e   Ben Amor, Imed ^b   Saint Paul, Marie Christine ^a,b   Mariné Barjoan, Eugenia ^b   Pariente, Alexandre ^f   Gugenheim, Jean ^a,b,c   Gual, Philippe ^a,b,c   Tran, Albert ^a,b,c  

^a INSERM   (France)

^b UNIVERSITY HOSPITAL OF NICE   (France)

^c UNIVERSITÉ CÔTE D'AZUR   (France)

^d HOSPICES CIVILS DE LYON   (France)

^e UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

^f CENTRE HOSPITALIER DE PAU   (France)

Author keywords

Espresso; Fatty liver; Metabolic syndrome; Regular coffee; Severely obese patients

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CAFFEINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BARIATRIC SURGERY; COFFEE; COHORT ANALYSIS; CORRELATION COEFFICIENT; DIETARY INTAKE; ESPRESSO COFFEE; EUROPEAN AMERICAN; FEMALE; HUMAN; INDEPENDENT VARIABLE; LIVER BIOPSY; LIVER FIBROSIS; LIVER PROTECTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORBID OBESITY; MULTIVARIATE ANALYSIS; NONALCOHOLIC FATTY LIVER; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; QUESTIONNAIRE; SCORING SYSTEM; UNIVARIATE ANALYSIS; WOMEN'S HEALTH;

ADULT; BARIATRIC SURGERY; BIOPSY; CACAO; CAFFEINE; COFFEE; COHORT STUDIES; COLA; COMORBIDITY; EUROPE; FATTY LIVER; FEMALE; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; OBESITY, MORBID; QUESTIONNAIRES; TEA;

EID: 84867574518     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.07.014     Document Type: Article

References (29)

1. V. Ratziu, S. Bellentani, H. Cortez-Pinto, C. Day, and G. Marchesini A position statement on NAFLD/NASH based on the EASL 2009 special conference J Hepatol 53 2010 372 384
2. A.L. Fracanzani, L. Valenti, E. Bugianesi, E. Vanni, A. Grieco, and L. Miele Risk of non alcoholic steatohepatitis and fibrosis in patients with non alcoholic fatty liver disease and low visceral adiposity J Hepatol 54 2010 1244 1249
3. E. Zimmermann, R. Anty, J. Tordjman, A. Verrijken, P. Gual, and A. Tran C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients J Hepatol 55 2011 660 665
4. G.S. Masterton, and P.C. Hayes Coffee and the liver: a potential treatment for liver disease? Eur J Gastroenterol Hepatol. 22 2010 1277 1283
5. I.S. Cadden, N. Partovi, and E.M. Yoshida Review article: possible beneficial effects of coffee on liver disease and function Aliment Pharmacol Ther. 26 2007 1 8
6. U. Gelatti, L. Covolo, M. Franceschini, F. Pirali, A. Tagger, and M.L. Ribero Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology: a case-control study J Hepatol 42 2005 528 534
7. A. Birerdinc, M. Stepanova, L. Pawloski, and Z.M. Younossi Caffeine is protective in patients with non-alcoholic fatty liver disease Aliment Pharmacol Ther 35 2012 76 82
8. J.W. Molloy, C.J. Calcagno, C.D. Williams, F.J. Jones, D.M. Torres, and S.A. Harrison Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis Hepatology 10 2011 24731
9. NIH conference Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel Ann Intern Med 115 1991 956 961
10. T. Wallace, and D. Matthews The assessment of insulin resistance in man Diabet Med 19 2002 527 534
11. K.G. Alberti, P. Zimmet, and J. Shaw Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation Diabet Med 23 2006 469 480
12. E.M. Brunt, C.G. Janney, A.M. Di Bisceglie, B.A. Neuschwander-Tetri, and B.R. Bacon Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions Am J Gastroenterol 94 1999 2467 2474
13. D.E. Kleiner, E.M. Brunt, M. Van Natta, C. Behling, M.J. Contos, and O.W. Cummings Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321
14. J.V. Higdon, and B. Frei Coffee and health: a review of recent human research Crit Rev Food Sci Nutr 46 2006 101 123
15. A.A. Modi, J.J. Feld, Y. Park, D.E. Kleiner, J.E. Everhart, and T.J. Liang Increased caffeine consumption is associated with reduced hepatic fibrosis Hepatology 51 2010 201 209
16. C.E. Costentin, F. Roudot-Thoraval, E.S. Zafrani, F. Medkour, J.M. Pawlotsky, and A. Mallat Association of caffeine intake and histological features of chronic hepatitis C J Hepatol 54 2011 1123 1129
17. K. Tanaka, M. Hara, T. Sakamoto, Y. Higaki, T. Mizuta, and Y. Eguchi Inverse association between coffee drinking and the risk of hepatocellular carcinoma: a case-control study in Japan Cancer Sci 98 2007 214 218
18. M. Montella, J. Polesel, C. La Vecchia, L. Dal Maso, A. Crispo, and M. Crovatto Coffee and tea consumption and risk of hepatocellular carcinoma in Italy Int J Cancer 120 2007 1555 1559
19. N.D. Freedman, T.M. Curto, K.L. Lindsay, E.C. Wright, R. Sinha, and J.E. Everhart Coffee consumption is associated with response to peginterferon and ribavirin therapy in patients with chronic hepatitis C Gastroenterology 140 2011 1961 1969
20. O.A. Gressner Less Smad2 is good for you! A scientific update on coffee's liver benefits Hepatology 50 2009 970 978
21. T.W. Crozier, A. Stalmach, M.E. Lean, and A. Crozier Espresso coffees, caffeine and chlorogenic acid intake: potential health implications Food Funct 3 2012 30 33
22. S. Kalthoff, U. Ehmer, N. Freiberg, M.P. Manns, and C.P. Strassburg Coffee induces expression of glucuronosyltransferases by the aryl hydrocarbon receptor and Nrf2 in liver and stomach Gastroenterology 139 2010 1699 1710
23. X. Ouyang, P. Cirillo, Y. Sautin, S. McCall, J.L. Bruchette, and A.M. Diehl Fructose consumption as a risk factor for non-alcoholic fatty liver disease J Hepatol 48 2008 993 999
24. M.F. Abdelmalek, A. Suzuki, C. Guy, A. Unalp-Arida, R. Colvin, and R.J. Johnson Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease Hepatology 51 2010 1961 1971
25. J.S. Lim, M. Mietus-Snyder, A. Valente, J.M. Schwarz, and R.H. Lustig The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome Nat Rev Gastroenterol Hepatol 7 2010 251 264
26. L.H. Tetri, M. Basaranoglu, E.M. Brunt, L.M. Yerian, and B.A. Neuschwander-Tetri Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent Am J Physiol Gastrointest Liver Physiol 295 2008 G987 G995
27. T. Ma, B. Liaset, Q. Hao, R.K. Petersen, E. Fjaere, and H.T. Ngo Sucrose counteracts the anti-inflammatory effect of fish oil in adipose tissue and increases obesity development in mice PLoS One 6 2011 e21647
28. C.A. Roncal-Jimenez, M.A. Lanaspa, C.J. Rivard, T. Nakagawa, L.G. Sanchez-Lozada, and D. Jalal Sucrose induces fatty liver and pancreatic inflammation in male breeder rats independent of excess energy intake Metabolism 60 2011 1259 1270
29. M.J. Dekker, Q. Su, C. Baker, A.C. Rutledge, and K. Adeli Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome Am J Physiol Endocrinol Metab 299 2010 E685 E694